Literature DB >> 13667394

Imperfection: biochemical phobias and metabolic ambivalence.

D L DRABKIN.   

Abstract

Entities:  

Keywords:  BODY CONSTITUTION; METABOLISM

Mesh:

Year:  1959        PMID: 13667394     DOI: 10.1353/pbm.1959.0037

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


× No keyword cloud information.
  9 in total

1.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

2.  The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Authors:  J L Cunningham; M F Bullen; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

3.  Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.

Authors:  J L Cunningham; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

4.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

5.  Clinical significance of plasma imipramine levels.

Authors:  C J Walter
Journal:  Proc R Soc Med       Date:  1971-03

6.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

7.  Age related differences in the disposition of acetanilide.

Authors:  J R Playfer; J D Baty; J Lamb; C Powell; D A Price-Evans
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

8.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07

9.  Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.

Authors:  J L Cunningham; M J Leyland; I W Delamore; D A Evans
Journal:  Br Med J       Date:  1974-08-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.